Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Jonathan E. Lim M.D. | Co-Founder & Independent Chairman | -- | -- | 1972 |
| Mr. Zachary Hornby | CEO, President & Director | 721.05k | -- | 1979 |
| Dr. Christian Hassig Ph.D. | Chief Scientific Officer | 563.55k | -- | 1973 |
| Mr. David Hinkle | Senior VP of Finance & Controller | -- | -- | -- |
| Ms. Jessica Oien J.D. | Chief Legal Officer & Corporate Secretary | -- | -- | 1971 |
| Mr. Anthony Pinkerton Ph.D. | Senior Vice President of Drug Discovery | -- | -- | -- |
| Ms. Meredith Wesley | Senior Vice President of Talent & Culture | -- | -- | -- |
| Dr. Peter Krein Ph.D. | Senior Vice President of Precision Medicine | -- | -- | -- |
| Ms. Amy Berkley Ph.D. | Senior Vice President of Program Team | -- | -- | -- |
| Ms. Sara Weymer | Senior Vice President of Clinical Operations | -- | -- | -- |
Boundless Bio, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 64
Description
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA. The company's lead product candidate is ecDTx, BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 demonstrating central nervous system penetrance in preclinical models. The company offers ECHO, an ecDNA diagnostic test to detect ecDNA in patient tumor specimen; and Spyglass platform, a platform to identify druggable targets in oncogene amplified cancers. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
March 25, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission